Publicado sep 27, 2017



PLUMX
Almetrics
 
Dimensions
 

Google Scholar
 
Search GoogleScholar


Daniel Martín Arsanios

Rodrigo Alirio Bastidas Goyes

Aldair Chaar Hernández

Andrés Herazo Cubillos

Luis Mateo Beltrán Caro

Daniel Vesga Martín

##plugins.themes.bootstrap3.article.details##

Resumen

Resumen


Los casos de infecciones causadas por Staphylococcus aureus resistente a meticilina han aumentado durante la última década. Dentro de ellas, la neumonía necrotizante (NN) adquirida en la comunidad se ha encontrado en pacientes jóvenes, sanos y sin factores de riesgo, lo que ha generado cuadros de evolución rápida y potencialmente mortales. En este artículo se discuten factores epidemiológicos, fisiopatológicos, de diagnóstico, tratamiento y pronóstico de la NN por Staphylococcus aureus resistente a meticilina adquirida en la comunidad.

Keywords

Pneumonia, Staphylococcus aureus, PV leukocidin.neumonía, Staphylococcus aureus, leucocidina de Panton-Valentine

References
Referencias
1. Kassisse E, Gil J. Neumonía secundaria a Staphylococcus aureus resistente a meticilina. Neumol Pediatr. 2013;8(1):17-21.

2. Vedia AL De, Lista N, Piovano G. Staphylococcus aureus meticilino resistente adquirido en la comunidad: una nueva amenaza. Rev Am Med Respir. 2012;12(4):131-9.

3. Gómez CH, Perilla AM, González C, Valderrama SL, Vanegas N, Chavarro B, et al. Neumonía necrosante por Staphylococcus aureus extrahospitalario resistente a la meticilina: reporte de dos casos en Colombia. Biomédica. 2009;29(4):523-30.

4. Deurenberg R, Stobberingh E. The evolution of Staphylococcus aureus. Infect Genet Evol. 2008;8(6):747-763.

5. Jiménez N, Ocampo AM, Vanegas JM, Rodríguez EA, Mediavilla JR, Cheng L, et al. CC8 MRSA Strains Harboring SCCmec type IVc are Predominant in Colombian Hospitals. PlusONE. 2012;7(6): e38576.

6. Diep BA, Otto M. The role of virulence determinants in community-associated MRSA pathogenesise. Trends Microbiol. 2008;16(8):361-9.

7. Arias C, Rincón S, Chowdhury S, Martínez E, Coronell W, Reyes J, et al. MRSA USA300 clone and VREF--A U.S.-Colombian connection? N Engl J Med. 2008;359(20):2177-9.

8. Chávez M, Mancilla LI, Lucumi A. Caracterización de Staphylococcus aureus aislados del personal de salud de un hospital de mediana complejidad de la ciudad de Cali en el año 2012. Medicina Ac Col. 2014;36(1):13-26.

9. Lemaître C, Angoulvant F, Gabor F, Makhoul J, Bonacorsi S, Naudin J, et al. Necrotizing pneumonia in children report of 41 cases between2006 and 2011 in a French tertiary care center. Pediatr Infect Dis J. 2013;32(10):1146-9.

10. Gillet Y, Vanhems P, Lina G, Bes M, Vandenesch F, Floret D, et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis. 2008;46(3):S350–9.

11. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359(9308):753-9.

12. Kreienbuehl L, Charbonney E, Eggimann P. Community-acquired necrotizing pneumonia due to methicillin-sensitive Staphylococcus aureus secreting Panton-Valentine leukocidin: a review of case reports. Ann Intensive Care. 2011;1(1):52.

13. Gordon R, Lowy F. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2008;46:S350-9.

14. Hernández O. Caracterización del gen mecA de Staphylococcus aureus resistentes a meticilina aislados de tres grupos poblacionales de la ciudad de Medellín. Infectio. 2013;17:66-72.

15. Bustos J, Hamdan-Partida A, Gutiérrez-Cárdenas M. Staphylococcus aureus: la reemergencia de un patógeno en la comunidad. Rev. Biomed. 2006;17(4):287-305.

16. Pavia A. What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia? Infect Dis Clin North Am. 2013;27(1):157-75.

17. Niemann S, Ehrhardt C, Medina E, Warnking K, Tuchscherr L, Heitmann V, et al. Combined action of influenza virus and Staphylococcus aureus panton–valentine leukocidin provokes severe lung epithelium damage. J Infect Dis. 2012;206(1):138-48.

18. Diep BA, Chan L, Tattevin P, Kajikawa O, Martin TR, Basuino L, et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus panton–valentine leukocidin–induced lung inflammation and injury. Proc Natl Acad Sci USA. 2010;107(12):5587-92.

19. Passariello C, Nencioni L, Sgarbanti R, Ranieri D, Torrisi MR, Ripa S, et al. Viral hemagglutinin is involved in promoting the internalisation of Staphylococcus aureus into human pneumocytes during influenza A H1N1 virus infection. Int J Med Microbiol. 2011;301(2):97-104.

20. Scheiblauer H, Reinacher M, Tashiro M, Rott R, et al. Interactions between bacteria and influenza A virus in the development of influenza pneumonia. J Infect Dis. 1992;116(4):783-91.

21. Tashiro M, et al. Role of Staphylococcus protease in the development of influenza pneumonia. Nature. 1987;325:536-7.

22. Small C, Shaler C, McCormick S, Al E. Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lun. J Inmunol. 2010;184:2048-56.

23. Margolis P, Gadomski A. The rational clinical examination: Does this infant have pneumonia? JAMA. 1998;279(4):308-13.

24. Palafox M, et al. Diagnostic value of tachypnoea in pneumonia defined radiologically. Arch Dis Child. 2000;82(1):41-5.

25. Lynch T, Platt R, Gouin S, Larson C, Patenaude Y. Can we predict which children with clinically suspected pneumonia will have the presence of focal infiltrates on chest radiographs? Pediatrics. 2004;113(3 Pt 1):e186-9.

26. Mahabee-Gittens EM, Grupp-Phelan J, Brody AS, Donnelly LF, Bracey SE, Duma EM, et al. Identifying children with pneumonia in the emergency department. Clin Pediatr. 2005;44(5):427-35.

27. Maltezou H, Giamarellou H. Community-acquired methicillin-resistant Staphylococcus aureus infections. Int J Antimicrob Agents. 2006;27(2):87-96.

28. Wallin T, et al. Community-associated methicillin-resistant Staphylococcus aureus. Emerg Med Clin North Am. 2008;26(2):431-55.

29. Forbes M, Hawkes M, et al. Guidelines for the prevention and management of community associated methicillin resistant Staphylococcus aureus (CA-MRSA): a perspective for Canadian health care practitioners. J Infect Dis Med Microbiol. 2006;17(Suppl C):1B-24B.

30. Centers for Disease and Prevention (CDC). Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep. 2007;56(14):325-9.

31. Kollef M, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilatorassociated pneumonia. Chest. 1998;113:412-20.

32. Rubinstein E, et al. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008;46:S378-85.

33. Kumar A, Roberts D, Wood K, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589-96.

34. Liu C, Bater A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18-55.

35. Sanchez M, De la Torre M, Morales G, Peláez B, Tolón MJ, Domingo S, et al. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA. 2010;303(22):2260-4.

36. Arias C, Vallejo M, Reyes J, Panesso D, Moreno J, Castañeda E, et al. Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase. J Clin Microbiol. 2008;46(3):892-6.

37. Wigen C, Goetz M. Serotonin syndrome and linezolid. Clin Infect Dis. 2002;34:1651-2.

38. Hoffer F, Bloom DA, Colin AA, Fishman SJ. Lung abscess versus necrotizing pneumonia: implications for interventional therapy. Pediatr Radiol. 1999;29(2):87-91.

39. Hacimustafaoglu M, Celebi S, Sarimehmet H, Gurpinar A, Ercan I. Necrotizing pneumonia in children. Acta Paediatr. 2004;93(9):1172-7.

40. Westphal FL, Lima LC, Netto JC, Tavares E, Andrade Ede O, Silva Mdos S. Surgical treatment of children with necrotizing pneumonia. J Bras Pneumol. 2010;36(6):716-23.

41. Hayashi Y, Vaska VL, Baba H, Nimmo GR, Davis L, Paterson DL. Influenza-associated bacterial pathogens in patients with 2009 influenza A (H1N1) infection: impact of community-associated methicillin-resistant Staphylococcus aureus in Queensland, Australia. Intern Med J. 2012;42(7):755-60.

42. Stevens D, Ma Y, Salmi DB, McIndoo E, Wallace RJ, Bryant AE. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis. 2007;195(2):202-11.
Cómo citar
Arsanios, D. M., Bastidas Goyes, R. A., Chaar Hernández, A., Herazo Cubillos, A., Beltrán Caro, L. M., & Vesga Martín, D. (2017). Neumonía adquirida en la comunidad por Staphylococcus aureus resistente a meticilina. Universitas Medica, 58(3). https://doi.org/10.11144/Javeriana.umed58-3.stap
Sección
Artículos de revisión